Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Psa2g3575 ATGTCCGCCGCACCTGTGTCTGCTGGGAATGGTTCGTTTAAGCAGAAAGCAATGAATGCCTCAAACATTCTTAGAAATTCTTTGGCAAGAAAGGGCAGGCGGAGTAGCAAGGTCATGTCTGTTGAAATTGAGGATGTGCACGATGCTGAGGAGTTGAAAGCTGTTGAAGAGTTCCGTGAAGCTCTTATAGCGGATGATCTCCTCCCTGCAAAGCATGATGACTATCATATGATGCTTAGATTCCTGAAGGCCAGGAAATTTGAAGTCGATAAATCAAAGCTGATGTGGTCTGATATGCTGAAATGGAGGACGGAATTTGGTGCTGACACTATTGGGGAGGAATTTGAATTCAAGGAAATTGATGAAGTATTGAAATATTATCCACAAGGACATCATGGAGTAGACAAAGAAGGACGACCTGTGTACATAGAAAGATTAGGACAAGTCGATGCTGCCAAGATGATGCAAGTCACAACCATGGATCGCTATATCAAATACCATGTAAAGGAGTTTGAGAGGACATTTGATATAAAGTTTGCAGCTTGTTCCATTGCTGCCAAGAAACACATCGATCAAAGTACGACTATCCTGGATGTGGAGGGAGTGGGGCTTAAAAGCTTCAACAAACATGCTAGGGAACTTGTTACTCGCATTCAGAAGATTGATGGTGACAACTATCCAGAGACCTTGAATCGCATGTTCATCATCAATGCAGGTTCTGGATTTAGAATACTATGGAACACCGTAAAATCCTTCCTTGATCCCAAGACCACAGCAAAAATCCATGTTCTTGGCAACAAGTATGATACTAAGTTGCTTGAAGTAATTGATGCAAGTGAGTTGCCTGACTTTTTAGGAGGTACATGTACATGTGCTGATCAAGGAGGATGTATGCGTTCGGATAGGGGACCATGGACAGATGCAGATATATTGAAGATGGTTCAGAATGGTGCTCACAAATGTTCAAGAAAATCTGAGTCTCATGTTGAGGAAGATAACACAATTTCCGAGGAGGATCACAATGATTCTAAGTTGGAGGAAAATCTCACCTCACAGGTTTCTCCAATTTGTGAAGAGGTCCCTGCAACTAAAGTTTCTAAGCAAGAGGATTTAATCCCCGTGGATGATAAAACAACTGCTGAGAAAAAAGTTGACCTAATCACCGCGGATGATAAAAAAGCTTCTCAGAAAAAAATTGACGTGAGTGACCCCATGGCAACATCAACAGGTACTCGCAACACTCACACTTGCAGACTATAG 1260 0.4206 MSAAPVSAGNGSFKQKAMNASNILRNSLARKGRRSSKVMSVEIEDVHDAEELKAVEEFREALIADDLLPAKHDDYHMMLRFLKARKFEVDKSKLMWSDMLKWRTEFGADTIGEEFEFKEIDEVLKYYPQGHHGVDKEGRPVYIERLGQVDAAKMMQVTTMDRYIKYHVKEFERTFDIKFAACSIAAKKHIDQSTTILDVEGVGLKSFNKHARELVTRIQKIDGDNYPETLNRMFIINAGSGFRILWNTVKSFLDPKTTAKIHVLGNKYDTKLLEVIDASELPDFLGGTCTCADQGGCMRSDRGPWTDADILKMVQNGAHKCSRKSESHVEEDNTISEEDHNDSKLEENLTSQVSPICEEVPATKVSKQEDLIPVDDKTTAEKKVDLITADDKKASQKKIDVSDPMATSTGTRNTHTCRL* 420
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Psa2g3575 419 MobiDBLite consensus disorder prediction 401 419 - -
Psa2g3575 419 Pfam CRAL/TRIO, N-terminal domain 71 97 IPR011074 -
Psa2g3575 419 ProSiteProfiles CRAL-TRIO lipid binding domain profile. 119 293 IPR001251 -
Psa2g3575 419 MobiDBLite consensus disorder prediction 321 347 - -
Psa2g3575 419 MobiDBLite consensus disorder prediction 321 346 - -
Psa2g3575 419 SMART CRAL_TRIO_N_2 74 99 IPR011074 -
Psa2g3575 419 SUPERFAMILY CRAL/TRIO domain 119 315 IPR036865 -
Psa2g3575 419 SMART sec14_4 119 290 IPR001251 -
Psa2g3575 419 PRINTS Cellular retinaldehyde-binding protein signature 77 99 - -
Psa2g3575 419 PRINTS Cellular retinaldehyde-binding protein signature 246 265 - -
Psa2g3575 419 PRINTS Cellular retinaldehyde-binding protein signature 279 288 - -
Psa2g3575 419 Gene3D - 33 106 - -
Psa2g3575 419 PANTHER CRAL-TRIO DOMAIN-CONTAINING PROTEIN YKL091C-RELATED 11 397 - -
Psa2g3575 419 Gene3D - 107 319 IPR036865 -
Psa2g3575 419 PANTHER PHOSPHATIDYLINOSITOL/PHOSPHATIDYLCHOLINE TRANSFER PROTEIN SFH10-RELATED 11 397 - -
Psa2g3575 419 Pfam CRAL/TRIO domain 125 287 IPR001251 -
Psa2g3575 419 SUPERFAMILY CRAL/TRIO N-terminal domain 48 114 IPR036273 -
Psa2g3575 419 CDD SEC14 120 288 IPR001251 -
Psa2g3575 419 MobiDBLite consensus disorder prediction 391 419 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Psa2g3575 Psa-Chr2 389171438 389176015 Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Psa2g3575 53 284 Acyl Lipid Metabolism Gene Families AT5G47730 28.216 2.13e-19 87.0
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Psa2g3575 - - gmx:100527533 637.491
       

Event-related genes

Select Gene_1 Chr_1 Start_1 End_1 Gene_2 Chr_2 Start_2 End_2 Event_name
Psa2g3575 2 389171438 389176015 Psa4g2235 4 179897303 179901502 ECH
Psa2g3575 2 389171438 389176015 Psa2g3575 2 389171438 389176015 ECH
Psa7g4176 7 340182365 340186124 Psa2g3575 2 389171438 389176015 ECH